← Back to Search

Memory Training for Mild Cognitive Impairment

N/A
Recruiting
Led By Nancy Chiaravalloti
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
60 or older.
60 or older.
Must not have
Prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke).
Benzodiazepines and steroid use.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
Awards & highlights

Summary

This trial is testing whether a memory retraining program can help people with mild cognitive impairment (MCI). MCI is a common cognitive deficit that can negatively impact everyday life. The trial will test the effects of the memory retraining program on cognitive function and everyday life.

Who is the study for?
This trial is for individuals aged 60 or older who have been diagnosed with amnestic Mild Cognitive Impairment (MCI) and are fluent in English. It's not suitable for those with a history of stroke, neurological injuries/diseases, significant alcohol/drug abuse requiring inpatient treatment, use of benzodiazepines/steroids, or major psychiatric conditions like bipolar disorder or schizophrenia.
What is being tested?
The study tests the effectiveness of memory retraining exercises compared to placebo control exercises on improving learning and memory in people with MCI. Participants will be randomly assigned to one of the two groups and assessed through neuropsychological tests, daily functioning questionnaires, and optional functional neuroimaging before and after treatment.
What are the potential side effects?
Since this trial involves cognitive exercises rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during testing sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I am 60 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a stroke or a neurological condition like MS.
Select...
I am currently using benzodiazepines or steroids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
This trial's timeline: 3 weeks for screening, Varies for treatment, and four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Participation in everyday life
Verbal list learning
Secondary study objectives
Functional memory
Functional neuroimaging
Self-reported anxiety
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental GroupExperimental Treatment1 Intervention
The experimental group will receive memory retraining exercises administered on a laptop computer twice a week for five weeks (10 training sessions).
Group II: Placebo Control GroupPlacebo Group1 Intervention
The placebo control group will receive placebo memory exercises administered on a laptop computer twice a week for five weeks (10 placebo control sessions).

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER
193 Previous Clinical Trials
669,115 Total Patients Enrolled
Kessler FoundationLead Sponsor
178 Previous Clinical Trials
10,868 Total Patients Enrolled
University of MichiganOTHER
1,833 Previous Clinical Trials
6,423,008 Total Patients Enrolled

Media Library

Memory Retraining Exercises Clinical Trial Eligibility Overview. Trial Name: NCT05396248 — N/A
Mild Cognitive Impairment Research Study Groups: Experimental Group, Placebo Control Group
Mild Cognitive Impairment Clinical Trial 2023: Memory Retraining Exercises Highlights & Side Effects. Trial Name: NCT05396248 — N/A
Memory Retraining Exercises 2023 Treatment Timeline for Medical Study. Trial Name: NCT05396248 — N/A
~79 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top